Literature DB >> 23399089

Moderate oxidative stress and high antioxidative activity are associated with steatosis in Japanese males.

Takuya Imatoh1, Seiichirou Kamimura, Shinichi Tanihara.   

Abstract

BACKGROUND AND AIM: Steatosis is an increasingly common problem worldwide, accompanying increasing obesity. Recently, it has been suggested that oxidative stress plays an important role in development of fatty liver disease. We carried out an epidemiological study to clarify the role of oxidative stress and antioxidative activity in steatosis.
METHODS: This study was conducted with 184 male workers who had received their annual health checkup. Steatosis was confirmed using ultrasonography. Oxidative stress and antioxidative activity were assessed using the dROM test and the BAP test, respectively.
RESULTS: Steatosis was confirmed in 59 subjects (29.7%) by ultrasonography. There was no significant difference between cases and controls in BAP levels (2229.0 μmol/L vs. 2194.3μmol/L, p = 0.83). The steatosis group showed significantly lower dROM levels than the control group (332.7 U. CARR vs. 316.8 U. CARR, p < 0.05). In addition, we carried out logistic regression analysis to assess the combination between dROM levels and BAP levels. Subjects with high dROM levels and high BAP levels had 74% lower risk for steatosis than subjects with low dROM levels and high BAP levels.
CONCLUSIONS: Our results suggested that moderate oxidative stress and high antioxidative activity was associated with decreased steatosis risk in Japanese males.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23399089      PMCID: PMC5414532          DOI: 10.1111/cts.12007

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  19 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

3.  A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.

Authors:  S Bajaj; P Nigam; A Luthra; R M Pandey; D Kondal; S P Bhatt; J S Wasir; A Misra
Journal:  Indian J Med Res       Date:  2009-03       Impact factor: 2.375

4.  Redox regulation, gene expression and longevity.

Authors:  Yoko Honda; Masashi Tanaka; Shuji Honda
Journal:  Geriatr Gerontol Int       Date:  2010-07       Impact factor: 2.730

5.  Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Kaushal Madan; Payal Bhardwaj; Sandeep Thareja; Siddhartha D Gupta; Anoop Saraya
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

6.  Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.

Authors:  G Targher; L Bertolini; L Scala; G Zoppini; L Zenari; G Falezza
Journal:  Diabet Med       Date:  2005-10       Impact factor: 4.359

7.  Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.

Authors:  Sandhya Narasimhan; Kuppan Gokulakrishnan; Rangasamy Sampathkumar; Syed Farooq; Radhakrishnan Ravikumar; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Clin Biochem       Date:  2010-04-14       Impact factor: 3.281

8.  The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population.

Authors:  Chia-Hung Chiang; Chin-Chou Huang; Wan-Leong Chan; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  Clin Biochem       Date:  2010-09-19       Impact factor: 3.281

9.  Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

Authors:  Nicola Villanova; Simona Moscatiello; Stefano Ramilli; Elisabetta Bugianesi; Donatella Magalotti; Ester Vanni; Marco Zoli; Giulio Marchesini
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

10.  Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.

Authors:  Arnoldo Riquelme; Marco Arrese; Alejandro Soza; Arturo Morales; René Baudrand; Rosa María Pérez-Ayuso; Robinson González; Manuel Alvarez; Verónica Hernández; María José García-Zattera; Francisco Otarola; Brenda Medina; Attilio Rigotti; Juan Francisco Miquel; Guillermo Marshall; Flavio Nervi
Journal:  Liver Int       Date:  2008-07-16       Impact factor: 5.828

View more
  3 in total

1.  Relationship between Oxidative Stress, Physical Activity, and Vitamin Intake in Patients with Asthma.

Authors:  Akira Yamasaki; Yuji Kawasaki; Kenichi Takeda; Tomoya Harada; Yasuyuki Hasegawa; Takehito Fukushima; Ryota Okazaki; Haruhiko Makino; Yoshihiro Funaki; Yuriko Sueda; Akihiro Yamamoto; Jun Kurai; Masanari Watanabe; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

2.  The Effect of Piceatannol from Passion Fruit (Passiflora edulis) Seeds on Metabolic Health in Humans.

Authors:  Munehiro Kitada; Yoshio Ogura; Hiroko Maruki-Uchida; Masahiko Sai; Taeko Suzuki; Keizo Kanasaki; Yuna Hara; Hiromi Seto; Yuka Kuroshima; Itaru Monno; Daisuke Koya
Journal:  Nutrients       Date:  2017-10-18       Impact factor: 5.717

3.  Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial.

Authors:  Naomi Omi; Hideki Shiba; Eisaku Nishimura; Sakuka Tsukamoto; Hiroko Maruki-Uchida; Masaya Oda; Minoru Morita
Journal:  J Int Soc Sports Nutr       Date:  2019-09-10       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.